SLC2A1 and prostate carcinoma: The high expression of NPAS2 promotes the release of HIF-1A and key glycolytic genes (HK2, PKM2, GLUT1 and MCT4), enhancing glycolytic metabolite levels, thus inducing the progression of prostate cancer cells.